1. Home
  2. PLBC vs EBS Comparison

PLBC vs EBS Comparison

Compare PLBC & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plumas Bancorp

PLBC

Plumas Bancorp

HOLD

Current Price

$51.65

Market Cap

340.7M

Sector

Finance

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.08

Market Cap

466.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLBC
EBS
Founded
1980
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
340.7M
466.9M
IPO Year
2002
2006

Fundamental Metrics

Financial Performance
Metric
PLBC
EBS
Price
$51.65
$8.08
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$57.67
$12.00
AVG Volume (30 Days)
23.3K
616.5K
Earning Date
04-15-2026
04-30-2026
Dividend Yield
2.60%
N/A
EPS Growth
N/A
125.83
EPS
1.38
0.07
Revenue
N/A
$742,900,000.00
Revenue This Year
$25.59
$1.29
Revenue Next Year
$5.15
N/A
P/E Ratio
$37.32
$116.43
Revenue Growth
N/A
N/A
52 Week Low
$39.70
$5.62
52 Week High
$54.58
$14.06

Technical Indicators

Market Signals
Indicator
PLBC
EBS
Relative Strength Index (RSI) 50.21 42.97
Support Level $50.20 $7.73
Resistance Level $52.19 $8.95
Average True Range (ATR) 0.89 0.52
MACD -0.09 -0.04
Stochastic Oscillator 46.08 26.23

Price Performance

Historical Comparison
PLBC
EBS

About PLBC Plumas Bancorp

Plumas Bancorp provides banking products and services in Northeastern California and Northwestern Nevada, offering a range of deposit products for commercial and retail customers, including checking, savings, money market accounts, time deposits, retirement accounts, and sweep accounts for businesses and public entities, along with digital banking services such as mobile and internet banking, remote deposit, and electronic funds transfers, as well as other customary banking services. Its loan portfolio comprises commercial real estate, commercial and industrial, consumer, agricultural, residential real estate, and construction and land development loans, and the company generates its revenue from loans and investment securities, with additional income from service fees.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: